Pegasus Partners Ltd. Abbott Laboratories Transaction History

Pegasus Partners Ltd.

$991 Million
Q2 2024

A detailed history of Pegasus Partners Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Pegasus Partners Ltd. holds 6,620 shares of ABT stock, worth $745,676. This represents 0.07% of its overall portfolio holdings.

Number of Shares

6,620

Previous 7,220 8.31%

Holding current value

$745,676

Previous $820,000 16.22%

% of portfolio

0.07%

Previous 0.09%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$100.73 - $112.44 $60,438 - $67,464	-600 Reduced 8.31%	6,620 $687,000
Q1 2024 Apr 24, 2024	BUY	$109.52 - $120.96 $41,836 - $46,206	382 Added 5.59%	7,220 $820,000
Q1 2023 May 10, 2023	SELL	$96.86 - $114.01 $16,369 - $19,267	-169 Reduced 2.41%	6,838 $692,000
Q4 2022 Feb 09, 2023	SELL	$95.06 - $111.52 $61,313 - $71,930	-645 Reduced 8.43%	7,007 $769,000
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $29,124 - $33,721	-301 Reduced 3.78%	7,652 $740,000
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $612 - $740	-6 Reduced 0.08%	7,953 $864,000
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $240,126 - $292,818	2,106 Added 35.98%	7,959 $942,000
Q4 2021 Feb 09, 2022	SELL	$115.53 - $141.46 $1.01 Million - $1.24 Million	-8,738 Reduced 59.89%	5,853 $824,000
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $56,814 - $66,936	522 Added 3.71%	14,591 $1.75 Million
Q3 2019 Oct 24, 2019	SELL	$81.84 - $88.74 $73,656 - $79,866	-900 Reduced 6.01%	14,069 $1.18 Million
Q2 2019 Jul 30, 2019	SELL	$72.88 - $85.0 $77,252 - $90,100	-1,060 Reduced 6.61%	14,969 $1.26 Million
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $1.96 Million - $2.37 Million	-29,636 Reduced 64.9%	16,029 $1.28 Million
Q4 2018 Feb 01, 2019	SELL	$65.56 - $74.27 $315,278 - $357,164	-4,809 Reduced 9.53%	45,665 $3.3 Million
Q3 2018 Nov 07, 2018	BUY	$60.81 - $73.36 $117,971 - $142,318	1,940 Added 4.0%	50,474 $3.7 Million
Q2 2018 Jul 27, 2018	BUY	$57.57 - $63.54 $199,998 - $220,737	3,474 Added 7.71%	48,534 $2.96 Million
Q1 2018 May 09, 2018	BUY	$56.27 - $63.62 $325,803 - $368,359	5,790 Added 14.74%	45,060 $2.7 Million
Q4 2017 Feb 08, 2018	BUY	$53.68 - $57.47 $1.29 Million - $1.38 Million	24,092 Added 158.73%	39,270 $2.24 Million
Q3 2017 Nov 09, 2017	BUY	$48.06 - $53.64 $729,454 - $814,147	15,178	15,178 $810,000

Others Institutions Holding ABT

# of Institutions

3,138

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pegasus Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Pegasus Partners Ltd. with notifications on news.

Account

Pegasus Partners Ltd. Abbott Laboratories Transaction History